GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matinas BioPharma Holdings Inc (FRA:6LJ0) » Definitions » Deferred Policy Acquisition Costs

Matinas BioPharma Holdings (FRA:6LJ0) Deferred Policy Acquisition Costs


View and export this data going back to 2017. Start your Free Trial

What is Matinas BioPharma Holdings Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Matinas BioPharma Holdings Business Description

Traded in Other Exchanges
Address
1545 Route 206 South, Suite 302, Bedminster, NJ, USA, 07921
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.